Philip Mathuis pitched on the HealthTech Investor Summit !
Our CSO Professor Kevin Braeckmans is again on this year’s Clarivate list of highly cited researchers. We are proud.
Advancing Cell Therapy: Photothermal nanofibers enable macromolecule delivery in unstimulated human T cells
In the pursuit of refining adoptive T cell transfer, a critical facet of cell therapies, a recent study Ghent University delves into the application of Photothermal Electrospun Nanofibers (PEN) for intracellular delivery. This technique has proven efficient for activated T cells and now presents a promising avenue for unstimulated T cells.
Another milestone achieved by Charlotte Hinnekens from Ghent University who was able to generate CAR-NK cells by using photoporation.
Reach out if you wish to know more about the technology used. firstname.lastname@example.org
We are excited to announce a collaboration by three innovative startups: LiveDrop, Aenitis Technologies, and Trince. The event, titled “Gentle Technologies for Cell Processing”,
Trince received a VLAIO R&D grant to support activities for further developing its novel intracellular delivery technology towards clinical cell-based therapeutic applications. The project runs until April 2025 and has three main objectives:
(1) Successful engineering of human T cells with large effector molecules (plasmids, mRNA and CRISPR/Cas9 RNPs) while preserving T cell fitness and therapeutic efficacy, (2) Develop a prototype device for automated high-throughput transfection of T cells based on Trince’s proprietary photoporation technology and, (3) Successful internal and external evaluation of the automated high-throughput prototype device.
Trince is included in the “Emerging technologies & companies in cell & gene therapy manufacturing” review in the Tools of tomorrow issue of Cell & Gene Therapy insights.
Together with Revatis, we successfully used our LumiPore transfection platform to deliver macromolecules into equine and human mesenchymal stem cells.
We are proud to announce that Clarivate has included both our scientific co-founders in their prestigious list of Highly Cited Researchers for 2022.
With 82 citations within one year after publication, our Nature Nanotechnology tpaper has received the status of Hot Paper by Web of Science.